Search bioRxiv⌕ Search

Biology subjects

Otaki, N.

Publications and source records attributed to Otaki, N..

2 recordsLinked to original sources

Microfluidic Core-Shell Encapsulation Enables Scalable Generation of Apical-Out Intestinal Spheroids

Apical-out intestinal spheroids provide direct access to the lumen-facing epithelial surface, making them attractive three-dimensional models for studying epithelial barrier function, nutrient uptake, and luminal exposure. However, existing polarity-reversal methods typically require releasing spheroids from surrounding ECM gels and culturing them in suspension, which can compromise matrix-derived cues, promote fusion, increase size heterogeneity, and limit scalability. Here, we develop a microfluidic core-shell encapsulation strategy to scalably produce apical-out intestinal spheroids within uniform hydrogel microcapsules. These microcapsules consist of a Matrigel core surrounded by an agarose shell. Flow-focusing microfluidics first confines Caco-2 cells in Matrigel cores that provide instructive extracellular matrix cues, and particle-templated emulsification subsequently encloses each core within an inert agarose shell that prevents spheroid fusion and preserves batch uniformity. The method generated >100,000 microcapsules per experiment, with a mean shell diameter of 117 {micro}m, a coefficient of variation below 9%, and >90% single-spheroid formation efficiency. The resulting spheroids established apical-basolateral polarity, organised tight junctions, formed a dextran-excluding epithelial barrier, and exhibited fatty-acid uptake. This core-shell strategy provides an experimentally tractable platform for scalable intestinal epithelial modelling and may be extensible to other epithelial microtissue systems. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=42 SRC="FIGDIR/small/731294v2_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@16dc3forg.highwire.dtl.DTLVardef@d5d947org.highwire.dtl.DTLVardef@1abe79forg.highwire.dtl.DTLVardef@f39239_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗

High-throughput CRISPR live-cell imaging of low-frequency chromosomal events quantifies the latent efficiency of chromosome engineering

Abstract/SummaryQuantifying low-frequency chromosomal alterations in living cell populations at early stages is essential in many fields including cancer studies and chromosome engineering, yet selection-based readouts impose delays and can lose fragile positives before readout, biasing frequency estimates; CRISPR imaging rarely reports detection limits at 10^-4. Here, we developed High-throughput CRISPR Imaging (Hi-CRI), integrating engineered dCas9-sgRNA ribonucleoprotein (RNP) labeling, suppression of nonspecific aggregates via metabolic modulation and protease treatment, high-speed volumetric imaging by oblique plane microscopy, GPU-accelerated image analysis, and an explicit error-controlled detection-limit framework. Using per-cell signal-to-noise ratio calling, Hi-CRI achieves a 0.01% detection limit for target-positive cell fractions. In microcell-mediated chromosome transfer of a mouse artificial chromosome (MAC) into HT1080 recipients, Hi-CRI measured 0.03% MAC-positive cells among 184,235 recipients at day 1 post-fusion, versus 0.0007% by antibiotic-selection-based clonogenic assay at day 8 post-fusion, consistent with substantial loss before readout (pre-readout attrition). Hi-CRI enables viability-preserving, selection-independent quantification of low-frequency chromosomal states. TeaserRare chromosome events can be counted in living cells by high-throughput CRISPR imaging before selection hides them.

bioengineering↗